Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Springer

Showing results (191-200 of 280) with videos related to

Pageof 28
Sort By:
British Journal of Cancer|December 1, 1988
A cytotoxic agent can be generated selectively at cancer sitesK D Bagshawe, C J Springer, F Searle, et al.
Journal of Medicinal Chemistry|December 19, 1998
Self-immolative nitrogen mustard prodrugs for suicide gene therapyD Niculescu-Duvaz, I Niculescu-Duvaz, F Friedlos, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1997
Antibody-directed enzyme prodrug therapy: pharmacokinetics and plasma levels of prodrug and drug in a phase I clinical trialJ Martin, S M Stribbling, G K Poon, et al.
The Journal of Investigative Dermatology|September 21, 2001
Abundant expression of vasoactive intestinal polypeptide receptor VPAC2 mRNA in human skinT C Fischer, P Hartmann, C Löser, et al.
Vaccine|November 19, 2017
Development of a synthetic Vi polysaccharide vaccine for typhoid feverYawei Ni, Michael J Springer, Jianhua Guo, et al.
Folia Morphologica|May 30, 2017
Frontal aslant tract projections to the inferior frontal gyrusT Szmuda, M Rogowska, P Słoniewski, et al.
Cancer Research|May 19, 2007
Suicide gene therapy of human colon carcinoma xenografts using an armed oncolytic adenovirus expressing carboxypeptidase G2Silke Schepelmann, Lesley M Ogilvie, Douglas Hedley, et al.
Environmental Health Perspectives|October 26, 2001
Species of the toxic Pfiesteria complex, and the importance of functional type in data interpretationJ M Burkholder, H B Glasgow, N J Deamer-Melia, et al.
European Urology|January 1, 1991
Ileal bladder substitute: antireflux nipple or afferent tubular segment?U E Studer, T Spiegel, G A Casanova, et al.
Mutation Research|September 1, 1984
A report of the U.S. Environmental Protection Agency Gene-Tox Program. Evaluation of mutagenicity assays for purposes of genetic risk assessmentL B Russell, C S Aaron, F de Serres, et al.
Pageof 28

Showing results (191-200 of 280) with videos related to

Sort By:
Pageof 28
British Journal of Cancer|December 1, 1988
A cytotoxic agent can be generated selectively at cancer sitesK D Bagshawe, C J Springer, F Searle, et al.
Journal of Medicinal Chemistry|December 19, 1998
Self-immolative nitrogen mustard prodrugs for suicide gene therapyD Niculescu-Duvaz, I Niculescu-Duvaz, F Friedlos, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1997
Antibody-directed enzyme prodrug therapy: pharmacokinetics and plasma levels of prodrug and drug in a phase I clinical trialJ Martin, S M Stribbling, G K Poon, et al.
The Journal of Investigative Dermatology|September 21, 2001
Abundant expression of vasoactive intestinal polypeptide receptor VPAC2 mRNA in human skinT C Fischer, P Hartmann, C Löser, et al.
Vaccine|November 19, 2017
Development of a synthetic Vi polysaccharide vaccine for typhoid feverYawei Ni, Michael J Springer, Jianhua Guo, et al.
Folia Morphologica|May 30, 2017
Frontal aslant tract projections to the inferior frontal gyrusT Szmuda, M Rogowska, P Słoniewski, et al.
Cancer Research|May 19, 2007
Suicide gene therapy of human colon carcinoma xenografts using an armed oncolytic adenovirus expressing carboxypeptidase G2Silke Schepelmann, Lesley M Ogilvie, Douglas Hedley, et al.
Environmental Health Perspectives|October 26, 2001
Species of the toxic Pfiesteria complex, and the importance of functional type in data interpretationJ M Burkholder, H B Glasgow, N J Deamer-Melia, et al.
European Urology|January 1, 1991
Ileal bladder substitute: antireflux nipple or afferent tubular segment?U E Studer, T Spiegel, G A Casanova, et al.
Mutation Research|September 1, 1984
A report of the U.S. Environmental Protection Agency Gene-Tox Program. Evaluation of mutagenicity assays for purposes of genetic risk assessmentL B Russell, C S Aaron, F de Serres, et al.
Pageof 28